Evaluating Subjective Well-being in Schizophrenic Patients Treated With quetiapineXR® and Other Atypical Antipsychotics
Clinical trial NCT00689325 · COMPLETED
Trial details
- NCT number
- NCT00689325
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2008-04-01
- Primary completion
- 2010-01-01
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.